Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1988 Jul;32(7):957–961. doi: 10.1128/aac.32.7.957

Antimalarial agents: specific treatment regimens.

D J Krogstad 1, B L Herwaldt 1, P H Schlesinger 1
PMCID: PMC172324  PMID: 3056248

Full text

PDF
957

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aderounmu A. F., Salako L. A., Lindström B., Walker O., Ekman L. Comparison of the pharmacokinetics of chloroquine after single intravenous and intramuscular administration in healthy Africans. Br J Clin Pharmacol. 1986 Nov;22(5):559–564. doi: 10.1111/j.1365-2125.1986.tb02935.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Appleton B., Wolfe M. S., Mishtowt G. I. Chloroquine as a malarial suppressive: absence of visual effects. Mil Med. 1973 Apr;138(4):225–226. [PubMed] [Google Scholar]
  3. Botero D., Restrepo M., Montoya A. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria. Bull World Health Organ. 1985;63(4):731–737. [PMC free article] [PubMed] [Google Scholar]
  4. Boudreau E. F., Webster H. K., Pavanand K., Thosingha L. Type II mefloquine resistance in Thailand. Lancet. 1982 Dec 11;2(8311):1335–1335. doi: 10.1016/s0140-6736(82)91532-x. [DOI] [PubMed] [Google Scholar]
  5. Bruce-Chwatt L. J. Malaria and pregnancy. Br Med J (Clin Res Ed) 1983 May 7;286(6376):1457–1458. doi: 10.1136/bmj.286.6376.1457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bygbjerg I. C., Schapira A., Flachs H., Gomme G., Jepsen S. Mefloquine resistance of falciparum malaria from Tanzania enhanced by treatment. Lancet. 1983 Apr 2;1(8327):774–775. doi: 10.1016/s0140-6736(83)92070-6. [DOI] [PubMed] [Google Scholar]
  7. CANN H. M., VERHULST H. L. Fatal acute chloroquine poisoning in children. Pediatrics. 1961 Jan;27:95–102. [PubMed] [Google Scholar]
  8. Darlow B., Vrbova H., Gibney S., Jolley D., Stace J., Alpers M. Sulfadoxine-pyrimethamine for the treatment of acute malaria in children of Papua New Guinea. II. Plasmodium vivax. Am J Trop Med Hyg. 1982 Jan;31(1):10–13. doi: 10.4269/ajtmh.1982.31.10. [DOI] [PubMed] [Google Scholar]
  9. Don Michael T. A., Aiwazzadeh S. The effects of acute chloroquine poisoning with special reference to the heart. Am Heart J. 1970 Jun;79(6):831–842. doi: 10.1016/0002-8703(70)90371-6. [DOI] [PubMed] [Google Scholar]
  10. Ekue J. M., Simooya O. O., Sheth U. K., Wernsdorfer W. H., Njelesani E. K. A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria. Bull World Health Organ. 1985;63(2):339–343. [PMC free article] [PubMed] [Google Scholar]
  11. Garfinkel D., Mamelok R. D., Blaschke T. F. Altered therapeutic range for quinidine after myocardial infarction and cardiac surgery. Ann Intern Med. 1987 Jul;107(1):48–50. doi: 10.7326/0003-4819-107-1-48. [DOI] [PubMed] [Google Scholar]
  12. Gilles H. M., Lawson J. B., Sibelas M., Voller A., Allan N. Malaria, anaemia and pregnancy. Ann Trop Med Parasitol. 1969 Jun;63(2):245–263. doi: 10.1080/00034983.1969.11686625. [DOI] [PubMed] [Google Scholar]
  13. Gluzman I. Y., Schlesinger P. H., Krogstad D. J. Inoculum effect with chloroquine and Plasmodium falciparum. Antimicrob Agents Chemother. 1987 Jan;31(1):32–36. doi: 10.1128/aac.31.1.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Harinasuta T., Bunnag D., Lasserre R., Leimer R., Vinijanont S. Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria. Lancet. 1985 Apr 20;1(8434):885–888. doi: 10.1016/s0140-6736(85)91670-8. [DOI] [PubMed] [Google Scholar]
  15. Heissenbuttel R. H., Bigger J. T., Jr The effect of oral quinidine on intraventricular conduction in man: correlation of plasma quinidine with changes in QRS duration. Am Heart J. 1970 Oct;80(4):453–462. doi: 10.1016/0002-8703(70)90191-2. [DOI] [PubMed] [Google Scholar]
  16. Hoffman S. L., Rustama D., Dimpudus A. J., Punjabi N. H., Campbell J. R., Oetomo H. S., Marwoto H. A., Harun S., Sukri N., Heizmann P. RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia. Lancet. 1985 Nov 9;2(8463):1039–1040. doi: 10.1016/s0140-6736(85)90908-0. [DOI] [PubMed] [Google Scholar]
  17. Hurwitz E. S., Johnson D., Campbell C. C. Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand. Lancet. 1981 May 16;1(8229):1068–1070. doi: 10.1016/s0140-6736(81)92239-x. [DOI] [PubMed] [Google Scholar]
  18. Hutchinson D. B., Farquhar J. A. Trimethoprim-sulfamethoxazole in the treatment of malaria, toxoplasmosis, and pediculosis. Rev Infect Dis. 1982 Mar-Apr;4(2):419–425. doi: 10.1093/clinids/4.2.419. [DOI] [PubMed] [Google Scholar]
  19. Jiang J. B., Li G. Q., Guo X. B., Kong Y. C., Arnold K. Antimalarial activity of mefloquine and qinghaosu. Lancet. 1982 Aug 7;2(8293):285–288. doi: 10.1016/s0140-6736(82)90268-9. [DOI] [PubMed] [Google Scholar]
  20. KIEL F. W. CHLOROQUINE SUICIDE. JAMA. 1964 Oct 26;190:398–400. doi: 10.1001/jama.1964.03070170139030. [DOI] [PubMed] [Google Scholar]
  21. Karbwang J., Bunnag D., Breckenridge A. M., Back D. J. The pharmacokinetics of mefloquine when given alone or in combination with sulphadoxine and pyrimethamine in Thai male and female subjects. Eur J Clin Pharmacol. 1987;32(2):173–177. doi: 10.1007/BF00542191. [DOI] [PubMed] [Google Scholar]
  22. Klayman D. L. Qinghaosu (artemisinin): an antimalarial drug from China. Science. 1985 May 31;228(4703):1049–1055. doi: 10.1126/science.3887571. [DOI] [PubMed] [Google Scholar]
  23. Kramer S. L., Campbell C. C., Moncrieff R. E. Fulminant Plasmodium falciparum infection treated with exchange blood transfusion. JAMA. 1983 Jan 14;249(2):244–245. doi: 10.1001/jama.1983.03330260062034. [DOI] [PubMed] [Google Scholar]
  24. Krogstad D. J., Schlesinger P. H., Herwaldt B. L. Antimalarial agents: mechanism of chloroquine resistance. Antimicrob Agents Chemother. 1988 Jun;32(6):799–801. doi: 10.1128/aac.32.6.799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Looareesuwan S., Phillips R. E., White N. J., Kietinun S., Karbwang J., Rackow C., Turner R. C., Warrell D. A. Quinine and severe falciparum malaria in late pregnancy. Lancet. 1985 Jul 6;2(8445):4–8. doi: 10.1016/s0140-6736(85)90056-x. [DOI] [PubMed] [Google Scholar]
  26. Looareesuwan S., White N. J., Chanthavanich P., Edwards G., Nicholl D. D., Bunch C., Warrell D. A. Cardiovascular toxicity and distribution kinetics of intravenous chloroquine. Br J Clin Pharmacol. 1986 Jul;22(1):31–36. doi: 10.1111/j.1365-2125.1986.tb02876.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Main E. K., Main D. M., Krogstad D. J. Treatment of chloroquine-resistant malaria during pregnancy. JAMA. 1983 Jun 17;249(23):3207–3209. [PubMed] [Google Scholar]
  28. McGregor I. A., Wilson M. E., Billewicz W. Z. Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and placental weight. Trans R Soc Trop Med Hyg. 1983;77(2):232–244. doi: 10.1016/0035-9203(83)90081-0. [DOI] [PubMed] [Google Scholar]
  29. Overturf G. D. Use of trimethoprim-sulfamethoxazole in pediatric infections: relative merits of intravenous administration. Rev Infect Dis. 1987 Mar-Apr;9 (Suppl 2):S168–S176. doi: 10.1093/clinids/9.supplement_2.s168. [DOI] [PubMed] [Google Scholar]
  30. Phillips R. E., Warrell D. A., Edwards G., Galagedera Y., Theakston R. D., Abeysekera D. T., Dissanayaka P. Divided dose intramuscular regimen and single dose subcutaneous regimen for chloroquine: plasma concentrations and toxicity in patients with malaria. Br Med J (Clin Res Ed) 1986 Jul 5;293(6538):13–16. doi: 10.1136/bmj.293.6538.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Phillips R. E., Warrell D. A., White N. J., Looareesuwan S., Karbwang J. Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies. N Engl J Med. 1985 May 16;312(20):1273–1278. doi: 10.1056/NEJM198505163122001. [DOI] [PubMed] [Google Scholar]
  32. Reacher M., Campbell C. C., Freeman J., Doberstyn E. B., Brandling-Bennett A. D. Drug therapy for Plasmodium falciparum malaria resistant to pyrimethamine-sulfadoxine (Fansidar). A study of alternate regimens in Eastern Thailand, 1980. Lancet. 1981 Nov 14;2(8255):1066–1069. doi: 10.1016/s0140-6736(81)91274-5. [DOI] [PubMed] [Google Scholar]
  33. Rudnitsky G., Miller K. D., Padua T., Stull T. L. Continuous-infusion quinidine gluconate for treating children with severe Plasmodium falciparum malaria. J Infect Dis. 1987 May;155(5):1040–1043. doi: 10.1093/infdis/155.5.1040. [DOI] [PubMed] [Google Scholar]
  34. Schlesinger P. H., Krogstad D. J., Herwaldt B. L. Antimalarial agents: mechanisms of action. Antimicrob Agents Chemother. 1988 Jun;32(6):793–798. doi: 10.1128/aac.32.6.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Schwartz D. E., Weidekamm E., Mimica I., Heizmann P., Portmann R. Multiple-dose pharmacokinetics of the antimalarial drug Fansimef (pyrimethamine + sulfadoxine + mefloquine) in healthy subjects. Chemotherapy. 1987;33(1):1–8. doi: 10.1159/000238468. [DOI] [PubMed] [Google Scholar]
  36. Smrkovski L. L., Buck R. L., Alcantara A. K., Rodriguez C. S., Uylance C. V. In vitro mefloquine resistant Plasmodium falciparum from the Philippines. Lancet. 1982 Aug 7;2(8293):322–322. doi: 10.1016/s0140-6736(82)90285-9. [DOI] [PubMed] [Google Scholar]
  37. Taggart J. V., Earle D. P., Berliner R. W., Zubrod C. G., Welch W. J., Wise N. B., Schroeder E. F., London I. M., Shannon J. A. STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. III. THE PHYSIOLOGICAL DISPOSITION AND ANTIMALARIAL ACTIVITY OF THE CINCHONA ALKALOIDS. J Clin Invest. 1948 May;27(3 Pt 2):80–86. doi: 10.1172/JCI101977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Trenholme C. M., Williams R. L., Desjardins R. E., Frischer H., Carson P. E., Rieckmann K. H., Canfield C. J. Mefloquine (WR 142,490) in the treatment of human malaria. Science. 1975 Nov 21;190(4216):792–794. doi: 10.1126/science.1105787. [DOI] [PubMed] [Google Scholar]
  39. Tulpule A., Krishnaswamy K. Chloroquine kinetics in the undernourished. Eur J Clin Pharmacol. 1983;24(2):273–276. doi: 10.1007/BF00613831. [DOI] [PubMed] [Google Scholar]
  40. Walker O., Salako L. A., Alván G., Ericsson O., Sjöqvist F. The disposition of chloroquine in healthy Nigerians after single intravenous and oral doses. Br J Clin Pharmacol. 1987 Mar;23(3):295–301. doi: 10.1111/j.1365-2125.1987.tb03048.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Warrell D. A., Looareesuwan S., Warrell M. J., Kasemsarn P., Intaraprasert R., Bunnag D., Harinasuta T. Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. N Engl J Med. 1982 Feb 11;306(6):313–319. doi: 10.1056/NEJM198202113060601. [DOI] [PubMed] [Google Scholar]
  42. Wattanagoon Y., Phillips R. E., Warrell D. A., Silamut K., Looareesuwan S., Nagachinta B., Back D. J. Intramuscular loading dose of quinine for falciparum malaria: pharmacokinetics and toxicity. Br Med J (Clin Res Ed) 1986 Jul 5;293(6538):11–13. doi: 10.1136/bmj.293.6538.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. White N. J., Looareesuwan S., Warrell D. A., Chongsuphajaisiddhi T., Bunnag D., Harinasuta T. Quinidine in falciparum malaria. Lancet. 1981 Nov 14;2(8255):1069–1071. doi: 10.1016/s0140-6736(81)91275-7. [DOI] [PubMed] [Google Scholar]
  44. White N. J., Looareesuwan S., Warrell D. A., Warrell M. J., Chanthavanich P., Bunnag D., Harinasuta T. Quinine loading dose in cerebral malaria. Am J Trop Med Hyg. 1983 Jan;32(1):1–5. doi: 10.4269/ajtmh.1983.32.1. [DOI] [PubMed] [Google Scholar]
  45. White N. J., Warrell D. A., Chanthavanich P., Looareesuwan S., Warrell M. J., Krishna S., Williamson D. H., Turner R. C. Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med. 1983 Jul 14;309(2):61–66. doi: 10.1056/NEJM198307143090201. [DOI] [PubMed] [Google Scholar]
  46. White N. J., Watt G., Bergqvist Y., Njelesani E. K. Parenteral chloroquine for treating falciparum malaria. J Infect Dis. 1987 Feb;155(2):192–201. doi: 10.1093/infdis/155.2.192. [DOI] [PubMed] [Google Scholar]
  47. Wolfe M. S., Cordero J. F. Safety of chloroquine in chemosuppression of malaria during pregnancy. Br Med J (Clin Res Ed) 1985 May 18;290(6480):1466–1467. doi: 10.1136/bmj.290.6480.1466. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES